The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Holman Susan Hartjes since 2007.
The trader's CIK number is 1205664.
At the time of the last reporting, Holman Susan Hartjes was the COO of Uroplasty Inc. (stock ticker symbol UROP).
Also see all insider trading activities at Uroplasty Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | UPI | 0 | $0 | 90,500 | $392,497 | 0 | $0 |
| 2012 | UPI | 0 | $0 | 5,100 | $18,288 | 0 | $0 |
| 2011 | UPI | 0 | $0 | 42,229 | $267,207 | 10,000 | $43,099 |
| 2008 | UPI | 0 | $0 | 10,000 | $31,012 | 0 | $0 |
| 2007 | UPI | 250 | $875 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-03-04 | UPI | Sale | 16,772 | 4.03 | 67,557 |
| 2014-03-05 | UPI | Sale | 20,862 | 3.95 | 82,425 |
| 2014-03-06 | UPI | Sale | 366 | 3.92 | 1,436 |
| 2014-01-29 | UPI | Sale | 52,500 | 4.59 | 241,079 |
| 2012-02-01 | UPI | Sale | 5,100 | 3.59 | 18,288 |
| 2011-11-11 | UPI | Sale | 5,000 | 4.72 | 23,600 |
| 2011-09-09 | UPI | Sale | 7,229 | 5.20 | 37,561 |
| 2011-06-06 | UPI | Sale | 1,500 | 8.00 | 12,000 |
| 2011-06-07 | UPI | Sale | 100 | 8.01 | 801 |
| 2011-06-08 | UPI | Sale | 1,841 | 7.96 | 14,650 |
| 2011-06-03 | UPI | Sale | 2,559 | 8.00 | 20,459 |
| 2011-05-31 | UPI | Sale | 12,000 | 8.06 | 96,732 |
| 2011-06-02 | UPI | Option Ex | 10,000 | 4.31 | 43,099 |
| 2011-02-02 | UPI | Sale | 12,000 | 5.12 | 61,404 |
| 2008-06-05 | UPI | Sale | 2,800 | 3.23 | 9,052 |
| 2008-06-06 | UPI | Sale | 7,200 | 3.05 | 21,960 |
| 2007-11-20 | UPI | Buy | 250 | 3.50 | 875 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Holman Susan Hartjes (COO of Uroplasty Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.